Back
Lonza Group Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
46
LZAGF
Lonza Group
Last Price:
553.76
Seasonality Move:
10.7%
Sell
38
CRSP
CRISPR Therapeutics AG
Last Price:
53.83
Seasonality Move:
22.82%
Sell
46
Lonza Group (LZAGF)
is a Sell
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $546.00. The Score for LZAGF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- LZAGF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $53.73. The Score for CRSP is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $546.00
The current trend is moderately bearish and LZAGF is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $53.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight buying pressure.
LZAGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.78 | Sell |
| Relative Strength Index (14 RSI): | 41.56 | Sell |
| Chaikin Money Flow: | -50 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (562.86 - 602.44) | Sell |
| Bollinger Bands (100): | (418.94 - 568.38) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.45 | Sell |
| Relative Strength Index (14 RSI): | 25.99 | Sell |
| Chaikin Money Flow: | 494799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.85 - 68.89) | Sell |
| Bollinger Bands (100): | (59.68 - 76.4) | Sell |
LZAGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 558.33 | Sell |
| 20-day SMA: | 580.93 | Sell |
| 50-day SMA: | 556.65 | Sell |
| 200-day SMA: | 489.17 | Buy |
| 8-day EMA: | 558.96 | Sell |
| 20-day EMA: | 568.13 | Sell |
| 50-day EMA: | 550.54 | Sell |
| 200-day EMA: | 512.31 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.78 | Sell |
| 20-day SMA: | 60.67 | Sell |
| 50-day SMA: | 71.39 | Sell |
| 200-day SMA: | 59.48 | Sell |
| 8-day EMA: | 56.32 | Sell |
| 20-day EMA: | 60.49 | Sell |
| 50-day EMA: | 65.64 | Sell |
| 200-day EMA: | 62.59 | Sell |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.19 per share, a decrease this year of $2.60 per share, and an increase next year of $1.51 per share.
Lonza Group Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||